跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
达必妥 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Dupilumab Injection
Approved
生物制品
Dupilumab Injection
SANOFI WINTHROP INDUSTRIE
🇨🇳 National Medical Products Administration
Approval Date
Feb 18, 2025
Approval ID
8VIZttd2gRU
Company
SANOFI WINTHROP INDUSTRIE
Type
生物制品
Approval Details
Approval Id
8VIZttd2gRU
Approval Number
国药准字SJ20235004
Generic Name
度普利尤单抗注射液
Generic Name En
Dupilumab Injection
Trade Name
达必妥
Drug Type
生物制品
Dosage Form
注射剂
Strength
300mg(2.0mL)/支(预充式注射笔)
Reg Date
2025-02-18
Expired Date
2030-01-23
Company Name
SANOFI WINTHROP INDUSTRIE
Production Company Name
SANOFI WINTHROP INDUSTRIE
Company Detail Path
/organization/sanofi-winthrop-industrie
Production Company Detail Path
/organization/sanofi-winthrop-industrie
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 18, 2025
Approval ID
8VIZttd2gRU
Type
生物制品
Back to NMPA Approvals